These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12724584)

  • 1. Brachytherapy and drug-eluting stents.
    Moses JW
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():30B-32B; discussion 32B-33B. PubMed ID: 12724584
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracoronary beta radiation for in-stent restenosis in a patient with percutaneously treated hypertrophic cardiomyopathy and coronary artery disease.
    Jain D; Geist V; Katus HA; Richardt G
    J Invasive Cardiol; 2002 Dec; 14(12):751-5. PubMed ID: 12454339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late thrombosis after gamma-brachytherapy.
    Maehara A; Mintz GS; Weissman NJ; Bui AB; Castagna MT; Ajani AE; Pichard AD; Satler LF; Suddath WO; Kent KM; Yang N; Chan R; White L; Waksman R
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):455-8. PubMed ID: 12652494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
    Kim S; Almeda FQ; Tessalee M; Snell RJ; Nathan S; Thew S; Nguyen C; Chu JC; Schaer GL
    Cardiovasc Radiat Med; 2004; 5(1):9-14. PubMed ID: 15275626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cagey proposition.
    Ho YD; Lee DP
    J Invasive Cardiol; 2008 Jan; 20(1):28. PubMed ID: 18174615
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure.
    Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Michev I; Chieffo A; Rogacka R; Vitrella G; Airoldi F; Colombo A
    Am J Cardiol; 2004 Aug; 94(3):351-4. PubMed ID: 15276103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IIb or not IIb? Toward a rational application of left main stenting.
    Uretsky BF
    J Am Coll Cardiol; 2010 Jun; 55(23):2553-5. PubMed ID: 20513594
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracoronary brachytherapy for treatment of in-stent restenosis.
    Saleem MA; Aronow WS; Ravipati G; Moorthy CR; Singh S; Agarwal N; Monsen CE; Pucillo AL
    Cardiol Rev; 2005; 13(3):139-41. PubMed ID: 15831147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary stents reduce restenosis and repeat revascularizations and may also improve survival.
    Vik-Mo H; Bønaa KH
    Scand Cardiovasc J; 2004 Aug; 38(4):195-6. PubMed ID: 15553928
    [No Abstract]   [Full Text] [Related]  

  • 11. IVUS guidance results in lower in-stent restenosis: A chapter for a history book?
    Colombo A
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):322-3. PubMed ID: 12822149
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotics and stent type for primary PCI.
    Mukherjee D
    Lancet; 2011 Jun; 377(9784):2154-6. PubMed ID: 21665264
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis.
    Cha DH; Ajani AE; Cheneau E; Waksman R
    J Invasive Cardiol; 2002 Jul; 14(7):432-7. PubMed ID: 12082202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents.
    Mishkel GJ; Moore AL; Markwell S; Shelton MC; Shelton ME
    J Am Coll Cardiol; 2007 Jan; 49(2):181-4. PubMed ID: 17222728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unprotected left main bifurcation restenosis treated with a 2-stent technique.
    Wainstein MV; Wainstein RV; Ribeiro JP
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E200-5. PubMed ID: 22972629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late target lesion revascularization following drug-eluting stents - looking back and forward to success.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):304-5. PubMed ID: 18288752
    [No Abstract]   [Full Text] [Related]  

  • 17. Forget Mars and venus, men and women are from the same planet after all.
    Parikh PB; Gruberg L
    J Invasive Cardiol; 2012 Jun; 24(6):261-2. PubMed ID: 22684378
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms and methods to resolve edge effect.
    Kuchulakanti P; Lew R; Waksman R;
    J Invasive Cardiol; 2003 Jun; 15(6):363-6. PubMed ID: 12777680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional flow reserve-guided stent therapy for multivessel disease: taking a closer look.
    Applegate RJ
    J Am Coll Cardiol; 2010 Jun; 55(25):2822-4. PubMed ID: 20579538
    [No Abstract]   [Full Text] [Related]  

  • 20. Mismatch between angiographic result and surgical evidence.
    Vistarini N; Aubert S; Gandjbakhch I
    Ann Thorac Surg; 2008 Jul; 86(1):314. PubMed ID: 18573453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.